ARCHIVES

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

This article is from The Cancer Letter archive.

Vol. 31 No. 18 | May 6, 2005

Download PDF Visit The Full Archive

Related Articles

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007

In Brief: Fleming New ACCC President, Jennifer Guy President Elect; Rauscher Joins UNIMED Board

April 7, 1989

In Brief: Changes In Key Subcommittee chairmanships, Brooke’s Defeat Leave Direction In Doubt

November 17, 1978

New Organ Systems Concept Flow Discussed

October 18, 1985

Black Physicians, Community Group To work With NCI

April 21, 1989

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008